BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26064071)

  • 21. Outcomes of a nurse-managed service for stable HIV-positive patients in a large South African public sector antiretroviral therapy programme.
    Grimsrud A; Kaplan R; Bekker LG; Myer L
    Trop Med Int Health; 2014 Sep; 19(9):1029-39. PubMed ID: 25041716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retention in care and predictors of attrition among HIV-infected patients who started antiretroviral therapy in Kinshasa, DRC, before and after the implementation of the 'treat-all' strategy.
    Mayasi N; Situakibanza H; Mbula M; Longokolo M; Maes N; Bepouka B; Ossam JO; Moutschen M; Darcis G
    PLOS Glob Public Health; 2022; 2(3):e0000259. PubMed ID: 36962315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in Ethiopia: a retrospective follow-up study.
    Fentie DT; Kassa GM; Tiruneh SA; Muche AA
    BMC Infect Dis; 2022 Sep; 22(1):727. PubMed ID: 36071386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss to Follow-up and Death Among Individuals With Newly Diagnosed Human Immunodeficiency Virus Receiving Dolutegravir-Based First-Line Antiretroviral Treatment in Eastern Ethiopia: Implications for 95% United Nations Targets.
    Gemechu A; Mihret A; Aseffa A; Howe R; Seyoum B; Mulu A
    Open Forum Infect Dis; 2023 Nov; 10(11):ofad522. PubMed ID: 37953815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alarming attrition rates among HIV-infected individuals in pre-antiretroviral therapy care in Myanmar, 2011-2014.
    Oo MM; Gupta V; Aung TK; Kyaw NT; Oo HN; Kumar AM
    Glob Health Action; 2016; 9():31280. PubMed ID: 27562473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study.
    Kiwanuka G; Kiwanuka N; Muneza F; Nabirye J; Oporia F; Odikro MA; Castelnuovo B; Wanyenze RK
    BMC Infect Dis; 2018 Oct; 18(1):533. PubMed ID: 30355356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Lost to Follow Up from Antiretroviral Therapy Among Retroviral Infected Patients at Tuberculosis Centers in Public Hospitals of Benishangul-Gumuz, Ethiopia.
    Degavi G
    HIV AIDS (Auckl); 2021; 13():315-327. PubMed ID: 33790656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and predictors of treatment failure among children on first-line antiretroviral therapy in Amhara Region Referral Hospitals, northwest Ethiopia 2018: A retrospective study.
    Yihun BA; Kibret GD; Leshargie CT
    PLoS One; 2019; 14(5):e0215300. PubMed ID: 31042743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decentralizing Access to Antiretroviral Therapy for Children Living with HIV in Swaziland.
    Auld AF; Nuwagaba-Biribonwoha H; Azih C; Kamiru H; Baughman AL; Agolory S; Abrams E; Ellerbrock TV; Okello V; Bicego G; Ehrenkranz P
    Pediatr Infect Dis J; 2016 Aug; 35(8):886-93. PubMed ID: 26849157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
    Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
    J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study.
    Melaku Z; Lamb MR; Wang C; Lulseged S; Gadisa T; Ahmed S; Habtamu Z; Alemu H; Assefa T; Abrams EJ
    BMC Public Health; 2015 May; 15():462. PubMed ID: 25934178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Facility-Level Factors Influencing Retention of Patients in HIV Care in East Africa.
    Rachlis B; Bakoyannis G; Easterbrook P; Genberg B; Braithwaite RS; Cohen CR; Bukusi EA; Kambugu A; Bwana MB; Somi GR; Geng EH; Musick B; Yiannoutsos CT; Wools-Kaloustian K; Braitstein P
    PLoS One; 2016; 11(8):e0159994. PubMed ID: 27509182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India.
    Nimkar S; Valvi C; Kadam D; Rewari BB; Kinikar A; Gupte N; Suryavanshi N; Deluca A; Shankar A; Golub J; Bollinger R; Gupta A; Marbaniang I; Mave V
    HIV Med; 2018 Jul; 19(6):395-402. PubMed ID: 29573312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and acceptability of delivery of antiretroviral treatment in health centres by health officers and nurses in Ethiopia.
    Assefa Y; Kiflie A; Tekle B; Mariam DH; Laga M; Van Damme W
    J Health Serv Res Policy; 2012 Jan; 17(1):24-9. PubMed ID: 22096081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
    Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
    J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality and Loss to Follow up Before Initiation of Antiretroviral Therapy Among HIV-Infected Children Eligible for HIV Treatment.
    Alvarez-Uria G; Naik PK; Midde M; Pakam R
    Infect Dis Rep; 2014 May; 6(2):5167. PubMed ID: 25002959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community ART Support Groups in Mozambique: The Potential of Patients as Partners in Care.
    Jobarteh K; Shiraishi RW; Malimane I; Samo Gudo P; Decroo T; Auld AF; Macome V; Couto A
    PLoS One; 2016; 11(12):e0166444. PubMed ID: 27907084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of loss to follow-up in antiretroviral treatment for adult patients in the Oromia region, Ethiopia.
    Megerso A; Garoma S; Eticha T; Workineh T; Daba S; Tarekegn M; Habtamu Z
    HIV AIDS (Auckl); 2016; 8():83-92. PubMed ID: 27175095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.